Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001069

Drug Information
NameCarbinoxamine    
SynonymsCHEBI:3398; DivK1c_000819; Ethanamine, 2-((4-chlorophenyl)-2-pyridinylmethoxy)-N,N-dimethyl-; Allergefon; Prestwick0_000801; 486-16-8; Ethanamine, 2-((4-chlorophenyl)-2-pyridinylmethoxy)-N,N-dimethyl- (9CI); C16H19ClN2O; Carbinoxamina; 3505-38-2 (MALEATE); (+-)-Carbinoxamine; 5-21-03-00492 (Beilstein Handbook Reference); Spectrum4_000264; L000924; KBio2_005656; Ethanamine, 2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethyl-; {2-[(4-Chlorophenyl)-2-pyridylmethoxy]ethyl}dimethylamine; Clistine; Spectrum5_000700; Prestwick3_000801; 59811-38-0; Carbinoxamine base; D07617; Spectrum_000100; Rotoxamine; Carbinoxaminum [INN-Latin]; Spectrum2_001127; UNII-VED9E376NC; AC1L1DYK; 2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]-N,N-dimethylethanamine; BRD-A29426959-050-05-8; Clistin; Paracarinoxamine; BSPBio_001933; AKOS003334261; UNII-982A7M02H5; KBioSS_000520; NCGC00166141-03; AB00053430; IDI1_000819; I14-3528; Carbinoxamine (INN); C06871; SPBio_000993; carbinoxamine; CID2564; Prestwick2_000801; 2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine; Carbinoxamine [INN:BAN]; Carbinoxaminum; KBio3_001153; DB00748; N,N-Dimethyl-2-(p-chloro-alpha-(2-pyridyl)benzyloxy)ethylamine; KBio2_003088; Ethanamine, 2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethyl-, (-)-; SBB067454; 2-{[(4-chlorophenyl)(pyridin-2-yl)methyl]oxy}-N,N-dimethylethanamine; Pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)-; Carbinoxamina [INN-Spanish]; KBioGR_000728; NCGC00166141-01; CHEMBL864; NCGC00166141-02; BSPBio_000661; EINECS 207-628-6; Ethanamine, 2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethyl-; Spectrum3_000327; NINDS_000819; McN-R 73Z; Prestwick1_000801; BRN 0250475; LS-131075; Paracarbinoxamine; AC-5507; KBio1_000819; Oprea1_764868; SPBio_002582; KBio2_000520; 2-[(4-chlorophenyl)-pyridin-2-ylmethoxy]-N,N-dimethylethanamine; BPBio1_000729    
Trade NameClistin; Palgic    
CompanyMcNeil Laboratories    
IndicationAllergic rhinitisApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntihistamine    
CAS NumberCAS 486-16-8
FormularC16H19ClN2O    
PubChem Compound IDCID 2564.    
PubChem Substance IDSID 9088.    
SuperDrug ATC IDR06AA08;    
SuperDrug CAS ID000486168;    
TargetHistamine H1 receptorAntagonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040442 To Reference
Ref 2Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol. 1994 Feb;349(2):140-4. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543